AI Avatar Behavioural Training for Pharma Commercial Teams — MUAS®/SOLO® Methodology

Ascentium Talent offers deep expertise at the intersection of AI simulation, pharmaceutical commercial training, and regulatory-compliant deployment. Our core capabilities include:

AI Avatar Design: Conversational AI roleplay scenarios replicating HCP interaction contexts — oncologists, cardiologists, rare disease specialists — with adaptive difficulty and real-time feedback.

Behavioural Assessment (MUAS®): Multi-Dimensional Uniform Adaptive Scenario methodology producing structured, auditable competency scores linked to observable behaviours — not self-reported sentiment.

Learning Outcome Measurement (SOLO®): Five-level academic framework operationalised for pharma rep development, enabling progression tracking from surface to deep competency.

Regulatory Architecture: Platform designed for EU AI Act compliance, GDPR Art. 28, Swiss nFADP, and pharma-specific requirements including 21 CFR Part 11 and GAMP 5 alignment.

Available to consult, co-develop, or deliver pilot programmes. Open to conversations with pharma L&D leaders, digital health innovators, and innovation programme managers across EMEA.